While the DEA continues to dig in on Schedule I status, deeming no medical benefit, the U.S. Department of Health and Human Services simultaneously holds a patent on cannabinoids for a wide range of medicinal purposes.
Kamēr DEA ķeras klāt 1. saraksta statusam, neskatot medicīnisko efektu, ASV Veselības un sociālo lietu departaments vienlaikus patur kanabionīdu patentu plaša mēroga medicīniskajiem nolūkiem.